Leerink Partnrs Issues Optimistic Forecast for BOLT Earnings
Bolt Biotherapeutics, Inc. (NASDAQ:BOLT – Free Report) – Investment analysts at Leerink Partnrs boosted their Q1 2025 earnings estimates for Bolt Biotherapeutics in a research note issued on Tuesday, March 25th. Leerink Partnrs analyst D. Graybosch now forecasts that the company will post earnings per share of ($0.34) for the quarter, up from their prior […]
Bolt Biotherapeutics, Inc. (NASDAQ:BOLT – Free Report) – Investment analysts at Leerink Partnrs boosted their Q1 2025 earnings estimates for Bolt Biotherapeutics in a research note issued on Tuesday, March 25th. Leerink Partnrs analyst D. Graybosch now forecasts that the company will post earnings per share of ($0.34) for the quarter, up from their prior […]
